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Abstract 
A total of 360 weanling barrows (Line 200 × 400, DNA Genetics; initial BW 12.4 ± 0.05 lb) were used in a 
42-d study to evaluate yeast-based pre- and probiotics (Phileo by Lesaffre, Milwaukee, WI) in diets with or 
without pharmacological levels of Zn on antimicrobial resistance (AMR) patterns of fecal Escherichia coli. 
Pens were assigned to 1 of 4 dietary treatments with 5 pigs per pen and 18 pens per treatment. Dietary 
treatments were arranged in a 2 × 2 factorial with main effects of live yeast-based pre- and probiotics 
(none vs. 0.10% ActiSafSc 47 HR+, 0.05% SafMannan, and 0.05% NucleoSaf from d 0 to 7, then 
concentrations were lowered by 50% from day 7 to 21) and pharmacological levels of Zn (110 vs. 3,000 
ppm from d 0 to 7, and 2,000 ppm from d 7 to 21 provided by ZnO). All pigs were fed a common diet from 
d 21 to 42 post-weaning without live yeast-based pre- and probiotics or pharmacological Zn. Fecal 
samples were collected on d 4, 21, and 42 from the same three pigs per pen for fecal E. coli isolation. The 
identification of E. coli was by PCR detection of uidA and clpB genes. The AMR patterns of E. coli were 
determined by microbroth dilution method using Sensititre CMV3AGNF panel containing 14 different 
antimicrobials. The addition of pharmacological levels of Zn had a marginally significant effect (P = 
0.051) to increase the minimum inhibitory concentration (MIC) values of ciprofloxacin; however, median 
MIC values were still under the Clinical and Laboratory Standards Institute (2018) classified resistant 
breakpoint for ciprofloxacin. There was no evidence for differences (P > 0.05) for yeast additives or Zn for 
AMR of fecal E. coli isolates to any of the remaining antibiotics. In conclusion, pharmacological levels of 
Zn tended to increase the AMR of fecal E. coli to ciprofloxacin while the medians were below a resistant 
breakpoint. There was no influence of live yeast and yeast extracts on AMR patterns of fecal E. coli 
against tested antimicrobials. 
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Summary
A total of 360 weanling barrows (Line 200 × 400, DNA Genetics; initial BW 12.4 ± 
0.05 lb) were used in a 42-d study to evaluate yeast-based pre- and probiotics (Phileo 
by Lesaffre, Milwaukee, WI) in diets with or without pharmacological levels of Zn on 
antimicrobial resistance (AMR) patterns of fecal Escherichia coli. Pens were assigned to 
1 of 4 dietary treatments with 5 pigs per pen and 18 pens per treatment. Dietary treat-
ments were arranged in a 2 × 2 factorial with main effects of live yeast-based pre- and 
probiotics (none vs. 0.10% ActiSafSc 47 HR+, 0.05% SafMannan, and 0.05% Nucle-
oSaf from d 0 to 7, then concentrations were lowered by 50% from day 7 to 21) and 
pharmacological levels of Zn (110 vs. 3,000 ppm from d 0 to 7, and 2,000 ppm from d 7 
to 21 provided by ZnO). All pigs were fed a common diet from d 21 to 42 post-weaning 
without live yeast-based pre- and probiotics or pharmacological Zn. Fecal samples were 
collected on d 4, 21, and 42 from the same three pigs per pen for fecal E. coli isolation. 
The identification of E. coli was by PCR detection of uidA and clpB genes. The AMR 
patterns of E. coli were determined by microbroth dilution method using Sensititre 
CMV3AGNF panel containing 14 different antimicrobials. The addition of pharma-
cological levels of Zn had a marginally significant effect (P = 0.051) to increase the 
minimum inhibitory concentration (MIC) values of ciprofloxacin; however, median 
MIC values were still under the Clinical and Laboratory Standards Institute (2018)5 
classified resistant breakpoint for ciprofloxacin. There was no evidence for differences 
(P > 0.05) for yeast additives or Zn for AMR of fecal E. coli isolates to any of the 
remaining antibiotics. In conclusion, pharmacological levels of Zn tended to increase 
the AMR of fecal E. coli to ciprofloxacin while the medians were below a resistant 
1 Department of Diagnostic Medicine/Pathology, College of Veterinary Medicine, Kansas State Univer-
sity.
2 Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University.
3 Department of Statistics, College of Arts and Sciences, Kansas State University.
4 Phileo by Lesaffre, Milwaukee, WI.
5 Clinical and Laboratory Standards Institute (CLSI). 2018. Performance standards for antimicrobial 
disk and dilution susceptibility tests for bacteria isolated from animals. Approved standard, 5th ed. CLSI 
supplement VET08. CLSI, Wayne, PA.
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breakpoint. There was no influence of live yeast and yeast extracts on AMR patterns of 
fecal E. coli against tested antimicrobials.
Introduction
Feeding pharmacological levels of Zn (2,000 to 3,000 ppm) has become a concern for 
AMR to antimicrobials of importance to human and animal medicine. One potential 
replacement strategy for pharmacological levels of Zn in the early nursery is the use of 
pre- and probiotics. This report is a companion to our previous paper in which we eval-
uated the effects of pharmacological levels of Zn with or without the addition of the live 
yeast Saccharomyces cerevisiae strain NCYC Sc 47 and yeast-based prebiotics derived 
from Saccharomyces cerevisiae on weanling pig growth performance.6 This paper reports 
the effects of live yeast and yeast-based prebiotics on AMR patterns for E. coli isolated 
from nursery pig feces.
Materials and Methods
General
The Kansas State University Institutional Animal Care and Use Committee approved 
the protocol used in this experiment. The study was conducted at the Kansas State 
University Segregated Early Weaning Facility in Manhattan, KS. The facility has two 
identical barns that are completely enclosed, environmentally controlled, and mechani-
cally ventilated. Treatments were equally represented in each barn. Each pen contained 
a 4-hole, dry self-feeder and a cup waterer to provide ad libitum access to feed and 
water. Pens (4 × 4 ft) had metal tri-bar floors and allowed approximately 2.7 ft2/pig. 
Animals and treatment structure
A total of 360 barrows (Line 200 × 400, DNA Genetics; initially 12.4 ± 0.05 lb BW) 
were used in a 42-d study with 5 pigs per pen and 18 pens per treatment (9 pens per 
barn). Details as to pig allotment, experimental design, and diet preparation and anal-
ysis can be found in Chance et al. (2021).6
Briefly, dietary treatments were arranged in a 2 × 2 factorial with main effects of yeast-
based pre- and probiotics (none vs. 0.10% ActiSafSc 47 HR+, 0.05% SafMannan, 
and 0.05% NucleoSaf from d 0 to 7, then concentrations were lowered by 50% from 
day 7 to 21) and pharmacological levels of Zn (110 vs. 3,000 ppm from d 0 to 7, and 
2,000 ppm from d 7 to 21 provided by ZnO). All pigs were fed a common diet from 
d 21 to 42 post-weaning without added yeast products or pharmacological levels of Zn. 
The live yeast Saccharomyces cerevisiae strain NCYC Sc 47 (ActiSaf Sc 47 HR+; Phileo 
by Lesaffre, Milwaukee, WI) served as the yeast-based probiotic. The yeast-based prebi-
otics included a yeast cell wall fraction with concentrated mannan-oligosaccharides and 
β-glucans from Saccharomyces cerevisiae (SafMannan; Phileo by Lesaffre, Milwaukee, 
WI) and a yeast extract containing ≥6% unbound nucleotides from Saccharomyces cere-
visiae (NucleoSaf; Phileo by Lesaffre, Milwaukee, WI).
6 Chance, J. A., J. T. Gebhardt, J. M. DeRouchey, H. I. Calderón, M. D. Tokach, J. C. Woodworth, R. 
D. Goodband, and J. A. Loughmiller. 2021. Effects of Live Yeast and Yeast Extracts with and without 
Pharmacological Levels of Zinc on Nursery Pig Growth Performance and Fecal Consistency. Kansas 
Experimental Station Research Reports: Vol. 7, Issue 11.
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Fecal collection
Fecal samples were collected on d 4, 21, and 42 of the experiment to isolate E. coli and 
determine AMR. Fecal samples were collected directly from the rectum of the same 
three randomly selected pigs from each pen and pooled by pen to form one composite 
sample. Fecal samples were collected using a sterile, single-use cotton tipped applicator 
(Fisher Healthcare, Pittsburgh, PA), stored in a clean, single-use zipper storage bag 
placed on ice and delivered the same day to the laboratory of Dr. Raghavendra Amach-
awadi at the Kansas State University College of Veterinary Medicine for bacterial 
isolation and further characterization. 
E. coli isolation
Approximately 1 g of fecal sample was suspended in 9 mL of phosphate-buffered saline. 
Fifty microliters of the fecal suspension were then spread-plated onto a MacConkey 
agar (Becton Dickinson, Sparks, MD) for the isolation of E. coli. Two lactose-fer-
menting colonies were picked from each MacConkey agar; each colony was individually 
streaked onto a blood agar plate (Remel, Lenexa, KS) and incubated at 98.6°F for 24 h. 
An Indole test was done and indole-positive isolates were stored in cryo-protect beads 
(Cryocare, Key Scientific Products, Round Rock, TX) at -112°F. Species confirmation 
of E. coli was by polymerase chain reaction (PCR) detection of uidA and clpB genes.
Antimicrobial susceptibility testing of E. coli isolates
Antimicrobial susceptibility testing was done on E. coli isolates recovered on d 4, 21, 
and 42. The microbroth dilution method as outlined by the Clinical and Laboratory 
Standards Institute (CLSI, 2018)5 was used to determine the minimum inhibitory 
concentrations (MIC) of several antibiotics (Table 1). Each isolate, stored in cryo-pro-
tect beads, was streaked onto a blood agar plate and incubated at 98.6°F for 24 h. 
Individual colonies were suspended in demineralized water (Trek Diagnostic Systems, 
Cleveland, OH) and turbidity was adjusted to 0.5 McFarland turbidity standards. 
Then, 10 µL of the bacterial inoculum was added to Mueller–Hinton broth and 
vortexed to mix. A Sensititre automated inoculation delivery system (Trek Diagnos-
tics Systems) was used to dispense 100 µL of the culture into National Antimicrobial 
Resistance Monitoring System (NARMS) panel plates designed for Gram-negative 
(CMV3AGNF, Trek Diagnostic Systems) bacteria. Escherichia coli ATCC 25922 
(American Type Culture Collection, Manassas, VA) strain was included as quality 
control. Plates were incubated at 98.6°F for 18 h and bacterial growth was assessed 
using Sensititre ARIS and Vizion systems (Trek Diagnostic Systems). Clinical and 
Laboratory Standards Institute5 guidelines were used to classify each isolate as suscep-
tible, intermediate, or resistant according to the breakpoints established for each 
antimicrobial. The MIC values greater than the susceptible breakpoint but lower than 
the resistant breakpoint were considered intermediate. The antimicrobials evaluated 
included: amoxicillin/clavulanic acid 2:1 ratio, ampicillin, azithromycin, cefoxitin, ceft-
iofur, ceftriaxone, chloramphenicol, ciprofloxacin, gentamicin, nalidixic acid, strepto-
mycin, sulfisoxazole, tetracycline, and trimethoprim/sulfamethoxazole.
Statistical analysis
For each of the 14 antimicrobials, minimum inhibitory concentration (MIC) data 
were summarized with appropriate descriptive statistics by treatment group at each 
sampling day. Due to the lack of variability, MICs of tetracycline were excluded from 
the statistical analysis since all isolates were resistant. The MIC data of the remaining 
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antimicrobials were analyzed using the linear mixed model. To better achieve model 
assumptions, data underwent natural log transformation before statistical modeling. 
Statistical analysis was performed using the MIXED procedure of SAS (v. 9.4, SAS 
Inst., Inc., Cary, NC) with option DDFM=KR in the MODEL statement. Fixed effects 
of the model included Zn, yeast, time, and their second- and third-order interactions. 
Random effects included block and pen. Treatment effect was assessed via back-trans-
formed least squares means, i.e., geometric means of the MIC values. The variance-co-
variance structure of pen was taken as compound symmetry, first-order autoregressive, 
or unstructured according to the model fitting criteria. Differences between treatments 
were considered significant at P ≤ 0.05 and marginally significant at 0.05 < P ≤ 0.10.
Results and Discussion
From fecal samples collected and E. coli isolated, there were no two-way or three-way 
interactions observed for any of the antibiotics tested. Thus, MIC values of fecal E. coli 
isolates in response to the inclusion of yeast-based pre- and probiotics, pharmacological 
levels of Zn, and sampling day were further explored (Table2). 
All fecal E. coli isolates were susceptible to azithromycin, ciprofloxacin, gentamicin, 
nalidixic acid, sulfisoxazole, and trimethoprim/sulfamethoxazole at all three sampling 
time points (d 4, 21, and 42) regardless of the inclusion of live yeast and yeast extracts 
or pharmacological levels of Zn. Regardless of diet or sampling day, fecal E. coli isolates 
were intermediate to amoxicillin:clavulanic acid (2:1 ratio), ampicillin, cefoxitin, 
ceftiofur, and chloramphenicol. Fecal E. coli isolates from all dietary treatments were 
resistant to streptomycin at all three sampling time points. On d 4 and 21, fecal E. coli 
isolates were considered intermediate to ceftriaxone but were resistant on d 42 based off 
CLSI5 antimicrobial breakpoints for ceftriaxone. 
There was evidence for increased (P < 0.05) MIC values over time for ampicillin, cefox-
itin, ceftriaxone, ciprofloxacin, nalidixic acid, sulfisoxazole, and trimethoprim/sulfa-
methoxazole with a tendency (P < 0.10) for increased MIC values of chloramphenicol 
and gentamicin. Azithromycin was the only antibiotic that had evidence for decreased 
(P < 0.001) MIC values over time. 
Of the fecal samples collected and E. coli isolated, MICs were not influenced by the 
presence of dietary addition of live yeast and yeast extracts. Only fecal E. coli isolated 
from pigs fed pharmacological levels of Zn from d 0 to 21 had a marginally significant 
effect (P = 0.051) where the AMR to ciprofloxacin was higher compared to those that 
were not fed added Zn. However, all median MICs were still well under the CLSI5 
antimicrobial breakpoint for ciprofloxacin.
In conclusion, there was minimal impact on the AMR of fecal E. coli of pigs fed diets 
with pharmacological levels of Zn and/or yeast-based pre- and probiotics. However, 
feeding high levels of Zn tended to increase the possibility of fecal E. coli’s AMR to 
ciprofloxacin, but based on the breakpoint the isolates were considered susceptible. 
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Brand names appearing in this publication are for product identification purposes only. 
No endorsement is intended, nor is criticism implied of similar products not mentioned. 
Persons using such products assume responsibility for their use in accordance with current 
label directions of the manufacturer.
Table 1. Resistance breakpoints and evaluated concentrations for antimicrobials of National Antimicrobial Resis-











Amoxicillin:clavulanic acid 2:1 ratio Critically important ≤ 8/4 16/8 ≥ 32/16
Ampicillin Critically important ≤ 8 16 ≥ 32
Azithromycin Critically important ≤ 16 N/A3 ≥ 32
Cefoxitin Highly important ≤ 8 16 ≥ 32
Ceftiofur Critically important ≤ 2 4 ≥ 8
Ceftriaxone Critically important ≤ 1 2 ≥ 4
Chloramphenicol Highly important ≤ 8 16 ≥ 32
Ciprofloxacin Critically important ≤ 0.06 ≥ 0.12 ≥ 0.12
Gentamicin Critically important ≤ 4 8 ≥ 16
Nalidixic acid Critically important ≤ 16 N/A ≥ 32
Streptomycin Critically important ≤ 16 N/A ≥ 32
Sulfisoxazole Highly important ≤ 256 N/A ≥ 512
Tetracycline Highly important ≤ 4 8 ≥ 16
Trimethoprim/sulfamethoxazole 1:19 ratio Highly important ≤ 2/38 N/A ≥ 4/76
1 Breakpoints established by Clinical and Laboratory Standards Institute (CLSI, 2018) which are categorized as susceptible (treatable), intermediate 
(possibly treatable with higher doses), and resistant (not treatable). The MIC values greater than the susceptible breakpoint but lower than the resistant 
breakpoint were considered intermediate. (Clinical and Laboratory Standards Institute (CLSI). 2018. Performance standards for antimicrobial disk 
and dilution susceptibility tests for bacteria isolated from animals. Approved standard, 5th ed. CLSI supplement VET08. CLSI, Wayne, PA.)
2 World Health Organization (WHO) categorization of antimicrobials according to importance for human medicine (WHO, 2018).
3N/A = not applicable. The National Antimicrobial Resistance Monitoring System has not established breakpoints; therefore, there is no Clinical and 














































































Table 2. Main effects of yeast probiotics and pharmacological levels of Zn over time on antimicrobial susceptibilities of fecal Escherichia coli according to 







P =No yeast Yeast Low Zn High Zn 4 21 42
Amoxicillin:clavulanic 
acid 2:1 ratio5
13.5 ± 1.0 13.3 ± 1.0 0.905 13.1 ± 1.0 13.6 ± 1.0 0.721 11.3 ± 1.1a 14.4 ± 1.4a 14.7 ± 1.4a 0.134
Ampicillin 23.1 ± 1.7 24.3 ± 1.8 0.625 22.9 ± 1.7 24.4 ± 1.8 0.541 18.3 ± 2.1a 23.1 ± 1.9a 31.4 ± 0.6b <0.001
Azithromycin 9.2 ± 0.64 9.1 ± 0.63 0.876 8.8 ± 0.60 9.6 ± 0.66 0.272 11.7 ± 0.96b 6.8 ± 0.56a 9.7 ± 0.80b <0.001
Cefoxitin 13.5 ± 1.0 14.6 ± 1.1 0.367 13.0 ± 1.0 15.1 ± 1.1 0.112 11.9 ± 1.1a 14.1 ± 1.3ab 16.5 ± 1.6b 0.030
Ceftiofur 2.5 ± 0.30 2.7 ± 0.32 0.606 2.7 ± 0.32 2.4 ± 0.29 0.505 2.1 ± 0.33a 2.5 ± 0.39a 3.2 ± 0.49a 0.189
Ceftriaxone 2.6 ± 0.49 3.1 ± 0.58 0.443 3.1 ± 0.59 2.6 ± 0.48 0.336 1.9 ± 0.46a 2.4 ± 0.60a 4.9 ± 1.20b 0.011
Chloramphenicol 20.2 ± 1.3 20.7 ± 1.3 0.774 20.4 ± 1.3 20.4 ± 1.3 0.999 19.8 ± 1.6ab 18.3 ± 1.7a 23.5 ± 1.5b 0.087















Gentamicin 2.9 ± 0.43 3.7 ± 0.54 0.232 3.6 ± 0.52 3.0 ± 0.44 0.386 2.5 ± 0.41a 4.0 ± 0.65b 3.4 ± 0.55ab 0.072
Nalidixic acid 3.2 ± 0.23 3.2 ± 0.23 1.000 3.0 ± 0.21 3.4 ± 0.24 0.253 2.9 ± 0.25a 2.9 ± 0.21a 3.9 ± 0.40b 0.029
Streptomycin 50.1 ± 2.8 53.8 ± 3.0 0.288 51.1 ± 2.9 52.7 ± 3.0 0.633 51.7 ± 3.9a 51.3 ± 3.8a 52.8 ± 4.0a 0.958
Sulfisoxazole 217 ± 13 203 ± 12 0.447 208 ± 12 211 ± 13 0.879 176 ± 17a 219 ± 15ab 239 ± 10b 0.010
Trimethoprim/Sulfa-
methoxazole 1:19 ratio5 0.25 ± 0.025 0.24 ± 0.025 0.848 0.23 ± 0.023 0.27 ± 0.027 0.210 0.20 ± 0.020b 0.15 ± 0.013a 0.51 ± 0.089c <0.001
1A total of 360 barrows (initially12.4 ± 0.05lb) were used in a 42-d study with 5 pigs per pen and 18 pens per treatment. Data reported as geometric mean of minimal inhibitory concentration (MIC) ± 
standard error of the mean. (Clinical and Laboratory Standards Institute (CLSI). 2018. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. 
Approved standard, 5th ed. CLSI supplement VET08. CLSI, Wayne, PA.)
2Fecal samples from the same 3 pigs/pen were collected on d 4, 21, and 42 for E. coli isolation and further characterization.
3Yeast pre- and probiotics included ActiSaf Sc 47 HR+ at 0.1%, SafMannan at 0.05% and NucleoSaf at 0.05% in phase 1 diets, and then concentrations were lowered by 50% in phase 2 diets (Phileo by 
Lesaffre, Milwaukee, WI).
4Zinc oxide was added to supply 3,000 ppm of Zn for the duration of phase 1, and 2,000 ppm of Zn for the duration of phase 2.
5The MIC numerator of the ratio was reported for the antimicrobial’s amoxicillin:clavulanic acid 2:1 ratio and trimethoprim/sulfamethoxazole 1:19 ratio.
a,b,c Superscripts signify statistical difference among sampling days at P < 0.05.
